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The main objective of this review is to explain the great potential of herbal plants as anticancer agents. Cancer is a disease caused by 
abnormal cell growth in the body. The high number of cancer incidents still become a global concern because of the high mortality rate. 
The treatments of cancer such as chemotherapy can cause serious side effects by killing the normal cells. This is the reason why it is 
necessary to develop an alternative treatment of cancer. I discussed a plant that is believed to has health benefit. Many studies have 
showed the positive effect of Tithonia diversifolia plant for health. After 2000, the researchers discovered a new potential through its 
cytotoxicity to neoplastic cells. This plant needs to be developed sustainably. However, in the future this plant might become an effective 
alternative to treat cancer with lower side effects. 
 





Cancer is a disease with a multifactorial etiology which 
is initiated by an abnormal and uncontrolled expression 
of transcription factors. This can be affected by a gene 
mutation (Babazadeh et al., 2018). Cancer is one of the 
main causes of death in the world and still become a 
global concern. Cancer has the second highest risk of 
death with a mortality ratio of 1:6 or around 9.6 million 
deaths in 2018. The most common types of cancer in 
men are lung, prostate, colorectal, stomach, and liver 
and the most common types of cancer in women are 
breast, colorectal, lung, cervical and thyroid cancers 
(WHO, 2021). Cancer can develop in any part of the 
body and can spread (metastasize) to other parts of the 
body. Although some types of cancer can be similar in 
some ways, how they develop, grow, spread, and 
respond to drugs can be very different (American 
Cancer Society, 2021). 
The research and development data in 2019 showed 
the incidence of cancer in Indonesia reached 
136.2/100,000 population and reach 8th place in 
Southeast Asia. The highest incidence rate of cancer for 
men is lung cancer, which is 19.4 per 100,000 
population with an average death rate of 10.9 per 
100,000 population, while the highest incidence rate of 
cancer for women is breast cancer, which is 42.1 per 
100,000 population with an average 17 deaths per 
100,000 population (Kemenkes RI, 2019). 
Cancer treatment methods are still being developed. 
There are several types of local treatment such as 
surgery and radiation therapy, and systemic treatment 
such as chemotherapy, immunotherapy, or targeted 
therapy that can affect not only cancer cells but also the 
entire body (American Cancer Society, 2021). 
Understanding the causes, how they are formed, and 
especially the factors that promote or inhibit their 
growth required to solve the complex biological and 
medical problems. Currently, there are many successful 
results from cancer treatment. For example, over the 
past half century, the survival rate for childhood 
leukemia has increased from 10% to more than 80%. 
But the healing method (or extended remission) is 
difficult, and is only available to those who living in 
affluent countries. There is nothing like "medicine" for 
cancer, and much remains for medical researchers to do 
(Haussman, 2019). 
The cancer treatment ideally can stop the growth of 
cancer cells with a selective toxic effect on the targeted 
cancer cells without damaging other normal tissues. 
However, most of today's anticancer drugs are still 
potentially toxic to normal tissues. The condition can 
cause harmful side effects to the body. Therefore, the 
discovery of anti-cancer drugs that have more positive 
effects with low toxicity is being developed. Many 
potential phytopharmaceuticals have been investigated 
to find chemical elements in plants that are beneficial for 
treatment (Wahyuningsih et al., 2013). The development 
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shown the beneficial effects of medicinal plants and 
their bioactive compounds. The most common anti-
cancer mechanism is by inducing apoptosis in neoplastic 
cells. Currently, more than 25% of drugs used over the 
last 20 years are derived directly from plants. According 
to WHO, 80 percent of the world's population has 
benefited from traditional medicine (Aryan, 2018). 
Nowadays, the efforts to develop new anti-cancer 
medicines and particularly novel drug delivery systems 
should be done. It is important to improve the 
pharmacodynamics and bioavailability of drugs and to 
deliver specific drug concentration to cancer cells so it 
can produce minimum cytotoxic effects on normal cells 
(Babazadeh et al., 2018). 
 
 
Tithonia diversifolia CHARACTERIZATION 
 
The Asteraceae family is known for its therapeutic effect 
such as antihelmintic, anti-inflammatory, astringent, 
antispasmodics, cholesteric, antioxidant, anti-
hemorrhagic, antimicrobial, diuretics, and analgesics. 
One type of the species from this family is Tithonia 
diversifolia (Farias et al., 2019). T. diversifolia can be 
described as a flowering shrub-like species, growing up 
to over 2–3 m high. The flowers are 5–15 cm wide and 
shaped like a daisy. The leaves (15–30 cm long) can be 
described as sub-ovale, petiolate, 3- to 7-lobed delicately 
hairy, and alternately to oppositely arranged (Tagne at 
al., 2018). T. diversifolia (Hemsl.) A. Gray (Mexican 
sunflower) originally from Mexico and Central America, 
but is now widely known in various parts of the world as 
an ornamental plant and a plant used for medicine. 
There are more than 150 types of secondary metabolites 
isolated from T. diversifolia, including the sesquiterpene 
lactones thyrotundin, tagitinin A, and tagitinin C 
(Miranda et al., 2015). T. diversifolia can be found in 
tropical and subtropical climes. Traditionally, all parts of 
the plant especially the leaves, are used by people to 
treat wounds, musculoskeletal disorders, abscesses, 
dermatological conditions, stomach pains, oral treatment 
for diabetes, malaria, fever, hepatitis and infectious 
diseases. Some studies showed the heterogenous 
evidence from in vitro and in vivo research that 
supporting most of the traditional therapeutic claims. T. 
diversifolia can grow up for all year-round and used 
fresh or dry as traditional remedies in several cultures. 
All parts of the plant are useful include the leaves, 
flowers, stems and roots are mentioned in some 
ethnobotanical reports (Tagne et al., 2018). 
The studies on phytochemical screening not only 
showed the presence of metabolites phenolics, 
flavonoids and tannins but also absence of alkaloids and 
saponins in T. diversifolia ethanolic flower extract. 
Phenolics are well known for their antioxidants and 
antimicrobial properties. This plays a role in prevention 
activities of phenolic against infection and degenerative 
disease, inflammation and allergies through 
antioxidants, antimicrobial and protein or enzyme 
neutralization or modulation mechanism. The examples 
of phenolic compounds are flavonoids and tannins. 
Flavonoids have many beneficial health effect and 
physiological properties. Flavonoids have antioxidant 
effects, anti-inflammatory, anti-mutagenic, anti-
carcinogenic property and as a modulator to the function 
of cellular enzymes. It is also have a great potensial 
inhibitors of xanthine oxidase, cyclooxygenase, 
lipoxygenase and phosphoinositide 3-kinase. Tannins 
has antioxidant, anticarcinogenic and antimutagenic 
potential. Tannins are also known to accelerate blood 
clotting, lower blood pressure, lower serum lipid levels 
and modulation of immunoresponse. Terpenoids has an 
antibiotic, chemopreventive and therapeutic effects on 
cancer. Terpenoids have been developed in the 
prevention, inhibition and therapy of several diseases 
including cancer, antivirals, antimicrobial, anti-allergic, 
antispasmodic, antidiabetic, anti-inflammatory, 
anticancer and immuno-modulatory properties (Gaule 
Ang et al., 2019).  
Farias et al, in 2019 also evaluate the composition, 
antioxidant, cytotoxic and microbiological activity of the 
essential oil of the leaves of the species T. diversifolia. 
The main constituent they was found are α-pinene 
(9.9%), Limonene (5.40%), (Z)-β-ocimene (4.02%), p-
cymen-8-ol (3.0%), Piperitone (11.72%), (E)-nerolidol 
(3.78%) and Spathulenol (10.8%). The activity of 
antioxidant from thee essential oil extracted from the 
leaves of T. diversifolia can be observed from the 
significant result with p < 0.0001 at the concentration of 
5 mgmL-1 with %AA 54.6 ± 0.06. The minimum 
inhibitory concentration (IC50) was 4.30 mgmL-1 , with 
a strong correlation coeffificient (R2) of 0.9965. 
Although T. diversifolia has good antioxidant activity, 




ANTI-CANCER POTENTIAL  
 
Activity-guided fractionation technique of an ethyl 
acetate extract from T. diversifolia, using an 
antiproliferative bioassay against human colon cancer 
cells (Col2), resulted in the isolation of three new 
sesquiterpenoids, 2R-hydroxytirotundin (1), 
tithofolinolide (2), and 3R-acetoxydiversifolol. (3), 
together with eight known sesquiterpene lactones, 3'-
acetoxy-8'-isobutyryloxyreynosine (4), tagitinin C (5), 
1',2Repoxytagitinin C (6), 4R,10R-dihydroxy-3-oxo-8'-
isobutyryloxyguaia -11(13)-en-12,6R-olide (7), 3R-
acetoxy4R-hydroxy-11(13)-eudesmen-12-oic acid 
methyl ester, 17,20-dihydroxygeranylnerol, tagitinin A, 
and thyrotundine. Measurement of antiproliferative 
activity in Col2 cells and induction of cellular 
differentiation in human promyelocytic leukemia (HL-
60) cells were carried out to determine the potential of 
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study, a culture test was used on rat breast organs that 
had been induced by 7,12-dimethylbenz[a]anthracene 
and the selected compound was tested for its ability to 
inhibit preneoplastic lesions. Isolates tagitinin C and 1',2 
Repoxytagitinin C showed significant antiproliferative 
activity. Isolat tithofolinolide, 3'-acetoxy-8'-
isobutyryloxyreynosine, and 4R,10R-dihydroxy-3-oxo-
8'-isobutyryloxyguaia -11(13)-en-12,6R-olide induced 
cellular differentiation of HL-60. The isolate 3'-acetoxy-
8'-isobutyryloxyreynosine significantly inhibited (63.0% 
at 10 μgmL-1) lesion formation in rat breast organ 
culture assays. Among these isolates there were several 
sesquiterpenoids and flavonoids that showed anti-human 
pro myelocytic leukemia (HL-60) activity and Tagitinin 
C was the main sesquiterpenoid that had been identified 
(Gu et al., 2002).  
The methanol extract of Tithonia diversifolia showed 
antiproliferative activity against glioblastoma cells 
U373, with an IC50 value of 59.2 ±3.7 μgmL-1, while 
tagitinin C showed an IC50 value of 6.1 ±0.1 μgmL-1. 
Based on flow cytometric analysis and pan-caspase 
inhibitory activity, the anti-glioblastoma effect was 
independent of apoptosis and it was concluded that 
tagitinin C induces U373 cell death through autophagy 
under certain conditions. Autophagy is a transport 
pathway to all eukaryotic cells. Cells degrade part of 
their own intracellular constituents, including cytoplasm 
and organelles. The first process for autophagi 
mechanism is the formation of a double membrane 
bound vacuole from endoplasmic reticulum. The 
autophagosomes receive hydrolases to form an 
autolysosome. This study also found that human 
glioblatoma U373 cell death induced by tagitinin C was 
apoptosis-independent and induced autophagosome (Lee 
at al., 2011). 
Another study showed the activity of the extract T. 
diversifolia in inhibiting the viability of keloid 
fibroblasts. Antifibrotic activity of the ethanolic extract 
of T. diversifolia on keloid fibroblast cell proliferation 
and collagen accumulation was expressed by the IC50 
value using probit regression analysis. The percentage of 
inhibition of keloid fibroblast proliferation increases 
gradually with the given dose extract of T. diversifolia 
with a very strong correlation (r = 0.838; p = 0.000 in 72 
hours; r = 0.924; p = 0.000 in 120 hours of incubation) 
with the lowest IC50 value of 3.624 μgmL-1 at an 
incubation time of 120 hours (Wahyuningsih et al., 
2015). Furthermore, Ranti et al, in 2018 tested the 
cytotoxic activity of tagitinin C on keloid fibroblast cells 
with IC50 values of 0.122 μgmL-1 (72 hours incubation) 
and 0.039 μgmL-1 (120 hours) which affected the 
deposition of 53.1% of keloid collagen (72 hours) and 
44.3% (120h). The selectivity index of tagitinin C in 
normal fibroblasts (NF) was 287 (72 hours incubation) 
and 791 for (120 hours incubation). Based on these 
results, it was concluded that the ability of tagitinin C to 
inhibit keloid fibrosis viability and reduce keloid 
collagen deposition was consistent with the 
concentration and incubation time. The process of 
collagen synthesis happened when the fibroblast got a 
stimulus from TGF-β that was bound to TGF-β receptors 
on the fibroblasts membrane. When an injury occured, 
the TGF-β will be separated from the binding protein 
give respond to mechanical trauma system. However, 
there have not been many studies on the inhibitory 
activity of TGF-β by T. diversifolia compound.  But, 
another study have found that the sesquiterpene lactones 
is known to inhibit the keloid fibroblasts proliferation, 
inhibit TGF-β1, and inhibit collagen synthesis of keloid 
through the NF-κB (Ranti et al., 2018). 
The next study was carried out by Wahyuningsih, et 
al in 2019 to determine the antifibrocytic mechanism of 
T. diversifolia extract. The study showed that the 
ethanolic extract of T. diversifolia at concentrations of 
20 gmL-1, 10 gmL-1, and 5 gmL-1 for 24 hours in keloid 
fibroblast culture showed slower migration activity 
compared to untreated keloid fibroblast culture (p<0, 
05). The study also showed that the expression of TGF-
β1 and VEGF in the treatment group given the ethanolic 
extract of T. diversifolia was significantly lower than 
untreated keloid fibroblasts (p<0.05). From those result, 
it can be concluded that the ethanolic extract of T. 
diversifolia can inhibit fibroblast migration activity and 
reduce the expression of VEGF and TGF-β1 in keloid 
fibroblasts. This mechanism further strengthens that T. 
diversifolia has great potential to be used as a keloid 
therapy (Wahyuningsih et al., 2019). 
Traditionally, T. diversifolia have been used to treat 
chronic hepatitis and liver diseases in Chinese herbal 
medicine. Further researh must be done to explore 
whether T. diversifolia can be used to treat hepatoma. 
(Lu et al., 2017). The study of the cytotoxic activity of 
the methanol extract of the leaves of T. diversifolia and 
tagitinin C against human hepatoma cells (Hep-G2) 
showed positive results.  The test results with the MTT 
assay showed IC50 values 40.0 ± 2.0 and 2.0 ± 0.1 
μgmL-1. This compound induces an increase population 
in the sub-G1, exhibited S phase arrest and results in the 
activation of caspase 3 and caspase 8 which confirms the 
data that the antiproliferative effect of this compound is 
through caspase-dependent apoptotic activity. Tagitinin 
C caused membrane blebbing, cell shrinkage, nuclear 
fragmentation, and chromatin condensation in hepatoma 
cells. Caspases, have an essential role in the regulation 
and the execution of apoptotic cell death. Caspase 3 well 
known as a key effector caspase in the apoptosis 
pathway, amplifying the signal from initiator caspases 
(such as caspase 8). This study show that tagitinin C 
induced apoptosis done by the activation of the caspase 
cascade (Liao at al., 2012). A follow-up study was 
conducted by Lu in 2017 to showed another cytotoxic 
effect of T. diversifolia on Hep G2 cells. The results of 
the study showed that the induction of apoptosis such as 
DNA fragmentation could increase the level of apoptosis 
and apoptosis of the sub-G1 population in the treatment 
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diversifolia. In addition, the acetate extract of the leaves 
of T. diversifolia was also increase the expression of the 
proapoptotic protein Bax Bcl-2. Based on this study, it 
prove the cytotoxicity induced by ethyl acetate extracts 
of T. diversifolia leaves (Td-L-EA) in human HepG2 
hepatoma cells that strengthen ethnopharmocologic use 
of T. diversifolia (Lu at., 2017). 
The cytotoxic effect of T. diversifolia leaf extract on 
RAW264.7 cells and human mononuclear peripheral 
blood cells (PBMC) by mitochondrial respiration 
method was also studied. The results of the study 
showed that the IC50 concentration in PBMC 
proliferation was 4.42 μgmL-1 and in RAW264.7 cells 
the IC50 value was 11.63 μgmL-1. The study 
demonstrated an immunomodulating effect by the leaf 
extract of T. diversifolia, which was produced the 
inhibition of phytohemagglutinin-M-induced PBMC 
proliferation and LPS-induced nitric oxide production in 
RAW264.7 macrophages. The hydrogen peroxide are 
able to induce cell death under stress conditions through 
apoptosis, but the anti-oxidant compound can protect 
this condition. The data showed that T. diversifolia 
aqueous extract showed an anti-oxidative capacity 
equivalent of (241.04 ± 11.93 mmol Troloxg-1) from 
ABTS assay and (94.89 ± 2.69 mmol Troloxg-1) from 
DPPH assay, respectively. The anti-oxidative capacity 
of T. diversifolia aqueous extract was equivalent to 
(32.62 ± 1.87) and (20.99 ± 2.79) mg NACg-1 in the 
ABTS and DPPH assays, when NAC was used as the 
standard compound. However, the calculated 
concentration was out of the non-cytotoxic range, which 
should be lower than 30 mg/mL. Thus, this calculated 
concentration based on the antioxidant capacity could 
not be used in practice in the hydrogen peroxide-induced 
cell death model.  
 It could be conclude that the effects of the 
immunomodulation caused by the aqueous extract from 
T. diversifolia. The mechanism can desccribe such as 
anti-PHA-M-induced PBMCs proliferation and antiLPS-
induced nitric oxide production from macrophages in the 






Based on the literature study, it is found that some 
isolate from the extract of Tithonia diversifolia 
(Hemsley) A. Gray) have the anticancer activity in 
several different types of cancer cells. The active 
substances contained in the leaves of the T. diversifolia. 
The compound material which has been known to 
become an anticancer alternative therapy is tagitinin C. 
The extract of the leaves T. diversifolia has several 
anticancer mechanisms related to antifibrotic activity 
and the induction of apoptosis. Further research can be 
develop to find out another potential compound from the 
T. diversifolia extract. We hope there will be a new 
chance to find better alternative therapy for cancer.  
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